| Trial ID: | L3299 |
| Source ID: | NCT02623465
|
| Associated Drug: |
Insulin Lispro
|
| Title: |
A Study of a New Type of Insulin in Participants With Type 2 Diabetes on Insulin Injection Therapy
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Insulin Lispro
|
| Outcome Measures: |
Primary: (Part A) Pharmacokinetics (PK): Area Under the Concentration Curve (AUC) of Insulin Lispro, (Part A) PK: AUC of Insulin Lispro, Time 0 to 5 hours post dose for each treatment on Day 1|(Part B) PK: AUC of Insulin Lispro Glucose Following a Mixed Meal, (Part B) PK: AUC of Insulin Lispro Glucose Following a Mixed Meal, Time 0 to 5 hours post dose on Day 1 and Day 14 of study treatment | Secondary: (Part A) Pharmacodynamics (PD): AUC of Glucose Following a Meal, (Part A) PD: AUC of Glucose Following a Meal, Time 0 to 5 hours post meal for each treatment on Day 1|(Part B) PD: AUC of Glucose Following a Meal, (Part B) PD: AUC of Glucose Following a Meal, Time 0 to 5 hours post meal on Day1 and Day14 of study treatment
|
| Sponsor/Collaborators: |
Sponsor: Eli Lilly and Company
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
|
| Start Date: |
2018-01
|
| Completion Date: |
2018-04
|
| Results First Posted: |
|
| Last Update Posted: |
2017-07-13
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT02623465
|
